Pearls of Wisdom

It’s a brave new world when it comes to financing startup and early stage biotechs, and particularly for pharmaceutical development groups. No longer are there hundreds of pharma-focused VC firms able to independently fuel and sustain the growth of drug development...

In the wake of the recent commotion surrounding flawed research at Duke University on diagnostic tools based on molecular patterns (“omics” tests), an Institute of Medicine (IOM) panel has issued a report entitled Evolution of Translational Omics: Lessons Learned and...

Save the date for the Eighth Annual Research Symposium presented by St. Vincent Health.  The event will be held on Wednesday June 13, 2012 from 7:00am-4:00pm at the Lilly Conference at the Marten House.  Topics to be discussed include Regulatory Updates, Family...

Pearl Pathways is excited to announce the release of its case studies.  Be sure to check out our case study section to see how Pearl offers real solutions to companies ranging from small startups to large multi-nationals.  Pearl is proud to share its work and the...

An article published this month by Susan J. Schniepp on BioPharm International illustrates the difficulty for contract manufacturing organizations (CMOs) in factoring in the quality priorities and needs of multiple clients into their own planning and operations.  The...